Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Heleen I Jansen in
Google Scholar
PubMed
Search for other papers by Marijn M Bult in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Endocrinology and Metabolism, Amsterdam, The Netherlands
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Jacquelien J Hillebrand in
Google Scholar
PubMed
the immunometric ECLIA assay (Gen I) on the Cobas e601 platform (Roche, reference interval 0.5–5.0 mU/L). Multilevel internal quality controls (Randox Immuno L1 and L2) were measured daily. The laboratory participated in the Dutch external quality
Search for other papers by Waleed K W Al-Badri in
Google Scholar
PubMed
Search for other papers by Hinke Marijke Jellema in
Google Scholar
PubMed
Search for other papers by Arnaud R G G Potvin in
Google Scholar
PubMed
Search for other papers by Ruth M A van Nispen in
Google Scholar
PubMed
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Search for other papers by Peerooz Saeed in
Google Scholar
PubMed
eyelid retraction, diplopia, and even corneal ulceration and optic neuropathy ( 1 ). All these clinical manifestations make GO a vision-threatening and disfiguring illness, heavily affecting the quality of life (QoL) and mental well-being of patients. GO
Search for other papers by Lukas Engler in
Google Scholar
PubMed
Search for other papers by Christian Adolf in
Google Scholar
PubMed
Search for other papers by Daniel A Heinrich in
Google Scholar
PubMed
Division of Interventional Cognitive Neurology, Department of Neurology, Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
Search for other papers by Anna-Katharine Brem in
Google Scholar
PubMed
Search for other papers by Anna Riester in
Google Scholar
PubMed
Search for other papers by Anna Franke in
Google Scholar
PubMed
Search for other papers by Felix Beuschlein in
Google Scholar
PubMed
Search for other papers by Martin Reincke in
Google Scholar
PubMed
Search for other papers by Axel Steiger in
Google Scholar
PubMed
Search for other papers by Heike Künzel in
Google Scholar
PubMed
affected than males ( 1 ). These patients were also found to have a lower quality of life (QoL) even after treatment with either a mineralocorticoid receptor (MR) antagonist or adrenalectomy (ADX) ( 2 ). Cognitive deficits are prevalent in depression ( 3
Universitat Oberta Catalunya (UOC), Barcelona, Spain
Search for other papers by Guillem Cuatrecasas in
Google Scholar
PubMed
Univ Autònoma de Barcelona, Cerdanyola del Vallès, Spain
Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain
Search for other papers by Hatice Kumru in
Google Scholar
PubMed
Search for other papers by M Josep Coves in
Google Scholar
PubMed
Univ Autònoma de Barcelona, Cerdanyola del Vallès, Spain
Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain
Search for other papers by Joan Vidal in
Google Scholar
PubMed
Cord Impact measurement) to evaluate the quality of live and functional recovery ( 19 ), modified Ashworth scales for spasticity ( 20 ) and neurophysiological tests (Motor (MEPs) and somatosensory evoked potentials (SEPs) to evaluate motor and
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Darling M Rojas-Canales in
Google Scholar
PubMed
St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia
The University of Melbourne, Department of Medicine, St. Vincent’s Hospital, Fitzroy, Victoria, Australia
Search for other papers by Michaela Waibel in
Google Scholar
PubMed
Search for other papers by Aurelien Forget in
Google Scholar
PubMed
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Daniella Penko in
Google Scholar
PubMed
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Jodie Nitschke in
Google Scholar
PubMed
Future Industries Institute, University of South Australia, Mawson Lakes, South Australia, Australia
Search for other papers by Fran J Harding in
Google Scholar
PubMed
Future Industries Institute, University of South Australia, Mawson Lakes, South Australia, Australia
Search for other papers by Bahman Delalat in
Google Scholar
PubMed
Future Industries Institute, University of South Australia, Mawson Lakes, South Australia, Australia
School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia
Search for other papers by Anton Blencowe in
Google Scholar
PubMed
St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia
Search for other papers by Thomas Loudovaris in
Google Scholar
PubMed
Transplantation Immunology Group, Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia
Search for other papers by Shane T Grey in
Google Scholar
PubMed
St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia
The University of Melbourne, Department of Medicine, St. Vincent’s Hospital, Fitzroy, Victoria, Australia
Search for other papers by Helen E Thomas in
Google Scholar
PubMed
St Vincent’s Institute of Medical Research, Fitzroy, Victoria, Australia
The University of Melbourne, Department of Medicine, St. Vincent’s Hospital, Fitzroy, Victoria, Australia
Search for other papers by Thomas W H Kay in
Google Scholar
PubMed
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Chris J Drogemuller in
Google Scholar
PubMed
Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia
Search for other papers by Nicolas H Voelcker in
Google Scholar
PubMed
Cooperative Research Centre for Cell Therapy Manufacturing (CRC-CTM), Adelaide, South Australia, Australia
Department of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, South Australia, Australia
Search for other papers by Patrick T Coates in
Google Scholar
PubMed
are required to measure blood glucose levels and inject insulin multiple times per day and often experience severe impairment of quality of life and potential long-term effects such as microvascular complications and organ damage ( 4 , 5 , 6 , 7
Search for other papers by S Westra in
Google Scholar
PubMed
Search for other papers by Y H M Krul-Poel in
Google Scholar
PubMed
Search for other papers by H J van Wijland in
Google Scholar
PubMed
Search for other papers by M M ter Wee in
Google Scholar
PubMed
Search for other papers by F Stam in
Google Scholar
PubMed
Search for other papers by P Lips in
Google Scholar
PubMed
Search for other papers by F Pouwer in
Google Scholar
PubMed
Search for other papers by S Simsek in
Google Scholar
PubMed
prevalences of depression, fatigue and (neuropathic) pain were found resulting in a decreased quality of life ( 2 , 3 , 4 , 5 , 6 ). Depressive symptoms and fatigue in people with diabetes are related to an increased risk of developing diabetes
Comprehensive Heart Failure Center, University & University Hospital Würzburg, Würzburg, Germany
Search for other papers by Ann-Cathrin Koschker in
Google Scholar
PubMed
Department of Psychiatry, Psychosomatics and Psychotherapy, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Bodo Warrings in
Google Scholar
PubMed
Division of Cardiology, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Caroline Morbach in
Google Scholar
PubMed
Search for other papers by Florian Seyfried in
Google Scholar
PubMed
Search for other papers by Nicole Rickert in
Google Scholar
PubMed
Search for other papers by Pius Jung in
Google Scholar
PubMed
Search for other papers by Andreas Geier in
Google Scholar
PubMed
Search for other papers by Ulrich Dischinger in
Google Scholar
PubMed
Search for other papers by Maike Krauthausen in
Google Scholar
PubMed
Search for other papers by Martin J Herrmann in
Google Scholar
PubMed
Department of General, Visceral, Transplant, Vascular, and Pediatric Surgery, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Christine Stier in
Google Scholar
PubMed
Division of Cardiology, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Stefan Frantz in
Google Scholar
PubMed
Search for other papers by Uwe Malzahn in
Google Scholar
PubMed
Division of Cardiology, Department of Internal Medicine I, University Hospital, University of Würzburg, Würzburg, Germany
Search for other papers by Stefan Störk in
Google Scholar
PubMed
Comprehensive Heart Failure Center, University & University Hospital Würzburg, Würzburg, Germany
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by the WAS Study Group in
Google Scholar
PubMed
regulation, exercise capacity, hemodynamic parameters, cardiac remodeling, and the quality of life (QoL). However, the evidence base explaining the influence of weight loss surgery on the heart remains poorly defined and mainly relies on non
Search for other papers by Ann-Kristin Picke in
Google Scholar
PubMed
Search for other papers by Graeme Campbell in
Google Scholar
PubMed
Division of Bone and Mineral Diseases, Washington University in St Louis, St Louis, Missouri, USA
Search for other papers by Nicola Napoli in
Google Scholar
PubMed
Search for other papers by Lorenz C Hofbauer in
Google Scholar
PubMed
Search for other papers by Martina Rauner in
Google Scholar
PubMed
progenitor cells (EPC) is reduced in T2DM leading to vessel permeability. In addition, T2DM causes microhypoxia in bone niche, which in turn increases inflammation. (7) T2DM patients have an increased risk of falls and fractures due to reduced bone quality
Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Hei Yi Vivian Pak in
Google Scholar
PubMed
Search for other papers by Andrew Lansdown in
Google Scholar
PubMed
Centre for Diabetes and Endocrinology, University Hospital of Wales, Cardiff, UK
Search for other papers by Peter Taylor in
Google Scholar
PubMed
Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, UK
Search for other papers by Dafydd Aled Rees in
Google Scholar
PubMed
Search for other papers by John Stephen Davies in
Google Scholar
PubMed
Cardiff University School of Medicine, Cardiff, UK
Search for other papers by Caroline Hayhurst in
Google Scholar
PubMed
problems, with a significant impact on both quality of life and life expectancy ( 4 , 5 ). Additionally, the diagnostic delay often shapes patients’ attitudes to health care professionals, which impacts on the quality of communication and subsequent
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Rong Xu in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Difei Lian in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Yan Xie in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Lin Mu in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Yali Wu in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Zhilei Chen in
Google Scholar
PubMed
Beijing Key Laboratory of Diabetes Research and Care, Beijing, China
Search for other papers by Baoyu Zhang in
Google Scholar
PubMed
by inhibiting bone formation by osteoblasts while promoting bone resorption by osteoclasts, finally leading to joint deformity and seriously affecting the quality of life ( 5 , 7 , 9 , 10 ). Besides, it has been reported that UA can inhibit the